Biofrontera (NASDAQ:BFRI) reported its Q1 earnings results on Friday, May 12, 2023 at 07:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Biofrontera missed estimated earnings by 47.37%, reporting an EPS of $-0.28 versus an estimate of $-0.19.
Revenue was down $1.02 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 10.24% drop in the share price the next day.
Here’s a look at Biofrontera’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.29 | -0.35 | -0.14 | -0.18 |
| EPS Actual | -0.14 | -0.16 | -0.24 | -0.19 | -0.15 |
| Revenue Estimate | 10.36M | 4.31M | 4.54M | 9.90M | 9.24M |
| Revenue Actual | 10.14M | 4.32M | 4.46M | 9.75M | 9.17M |
To track all earnings releases for Biofrontera visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
